Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

North America Clinical Laboratory Test Market

ID: MRFR/LS/1651-CR
85 Pages
Nidhi Mandole
Last Updated: January 13, 2026
North America Clinical Laboratory Test Market Research Report Information By Type of Laboratory (Hospital based, Central/Independent, Physician Office Laboratory, and Others), By Type of Test (CBC and Routine Blood Test, Anatomic Pathology, Molecular Test, Immunology Test, Drug Test, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Type of Laboratories (USD Billion)
      1. 4.1.1 Rigid
      2. 4.1.2 Flexible
    2. 4.2 Construction, BY Type of Tests (USD Billion)
      1. 4.2.1 Complete Blood Count (CBC)
      2. 4.2.2 Basic Metabolic Panel (BMP)
      3. 4.2.3 HbA1c Tests
      4. 4.2.4 HGB/HCT Tests
      5. 4.2.5 Comprehensive Metabolic Panel Tests
      6. 4.2.6 BUN Creatinine Tests
      7. 4.2.7 Renal Panel Tests
      8. 4.2.8 Electrolytes Testing
      9. 4.2.9 Liver Panel Tests & Lipid Panel Tests
    3. 4.3 Construction, BY Application (USD Billion)
      1. 4.3.1 Parasitology
      2. 4.3.2 Virology
      3. 4.3.3 Hematology
      4. 4.3.4 Toxicology
      5. 4.3.5 Immunology/Serology
      6. 4.3.6 Histopathology and Urinalysis
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Abbott Laboratories (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Roche Diagnostics (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Siemens Healthineers (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Thermo Fisher Scientific (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Danaher Corporation (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Becton Dickinson and Company (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 PerkinElmer Inc. (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 bioMérieux SA (FR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Ortho Clinical Diagnostics (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS BY TYPE OF LABORATORIES
    3. 6.3 NORTH AMERICA MARKET ANALYSIS BY TYPE OF TESTS
    4. 6.4 NORTH AMERICA MARKET ANALYSIS BY APPLICATION
    5. 6.5 KEY BUYING CRITERIA OF CONSTRUCTION
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF CONSTRUCTION
    8. 6.8 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    10. 6.10 SUPPLY / VALUE CHAIN: CONSTRUCTION
    11. 6.11 CONSTRUCTION, BY TYPE OF LABORATORIES, 2024 (% SHARE)
    12. 6.12 CONSTRUCTION, BY TYPE OF LABORATORIES, 2024 TO 2035 (USD Billion)
    13. 6.13 CONSTRUCTION, BY TYPE OF TESTS, 2024 (% SHARE)
    14. 6.14 CONSTRUCTION, BY TYPE OF TESTS, 2024 TO 2035 (USD Billion)
    15. 6.15 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
    16. 6.16 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Billion)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE OF LABORATORIES, 2025-2035 (USD Billion)
      2. 7.2.2 BY TYPE OF TESTS, 2025-2035 (USD Billion)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

North America Construction Market Segmentation

Construction By Type of Laboratories (USD Billion, 2025-2035)

  • Rigid
  • Flexible

Construction By Type of Tests (USD Billion, 2025-2035)

  • Complete Blood Count (CBC)
  • Basic Metabolic Panel (BMP)
  • HbA1c Tests
  • HGB/HCT Tests
  • Comprehensive Metabolic Panel Tests
  • BUN Creatinine Tests
  • Renal Panel Tests
  • Electrolytes Testing
  • Liver Panel Tests & Lipid Panel Tests

Construction By Application (USD Billion, 2025-2035)

  • Parasitology
  • Virology
  • Hematology
  • Toxicology
  • Immunology/Serology
  • Histopathology and Urinalysis